With further studies it is hoped that the FDA EUROPE will approve Epithalon for human use
doi:10.1007/s00592-020-01657-8 23
Among the mAbs that bind to the extracellular domain of c-MET, the fully humanized monovalent mAb onartuzumab (MetMAb, Genentech, South San Francisco, California, USA) has been evaluated in several clinical trials, but failed to show improvement when given in combination with erlotinib in patients with MET -positive NSCLC [21, 22, 99]
Wijesekara N, Dai FF, Hardy AB, Giglou PR, Bhattacharjee A, Koshkin V, et al
Children who received 25-50 mg/kg nicotinamide daily for five years showed no harmful effects
El resultado principal fue que el GLP-1 incrementa directamente la frecuencia cardaca (efecto cronotrpico positivo) actuando sobre los receptores del nodo sinusal, sin necesitar la participacin del sistema nervioso autnomo